Nicola's patent practice is principally focussed on chemical inventions, with particular experience in the fields of pharmaceutical and veterinary medicine, agrochemicals, subsea technologies, petrochemicals, batteries and ink technologies.
Nicola has considerable experience in securing patent protection in a range of chemical technologies. As well as prosecuting patent applications in Europe and the UK, Nicola is also involved in the management of international patent portfolios covering a wide variety of jurisdictions. She has also drafted patent applications in various technical fields, and has experience in oppositions and appeals matters at the European Patent Office.
Nicola graduated from the University of Durham in the UK with a first class honours degree in chemistry in 2003. She subsequently obtained a PhD in physical chemistry from the University of Bristol also in the UK. Her PhD research involved the study of the detailed electronic structure of various small molecules, using high resolution laser spectroscopy.
Nicola joined the patent profession in 2007, qualifying as a European Patent Attorney in 2011 and a Chartered Patent Attorney in 2012. Nicola joined the London office of HGF in September 2013, having previously worked elsewhere in private practice.
University of Durham
University of Bristol
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.